ID   BRSK2_HUMAN             Reviewed;         736 AA.
AC   Q8IWQ3; B3KVE9; E9PLM7; O60843; O95099; Q5J5B4; Q6ZMQ4; Q8TB60;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Serine/threonine-protein kinase BRSK2;
DE            EC=2.7.11.1;
DE   AltName: Full=Brain-selective kinase 2;
DE            EC=2.7.11.26;
DE   AltName: Full=Brain-specific serine/threonine-protein kinase 2;
DE            Short=BR serine/threonine-protein kinase 2;
DE   AltName: Full=Serine/threonine-protein kinase 29;
DE   AltName: Full=Serine/threonine-protein kinase SAD-A;
GN   Name=BRSK2; Synonyms=C11orf7, PEN11B, SADA, STK29; ORFNames=HUSSY-12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=16630837; DOI=10.1016/j.neuron.2006.03.018;
RA   Inoue E., Mochida S., Takagi H., Higa S., Deguchi-Tawarada M.,
RA   Takao-Rikitsu E., Inoue M., Yao I., Takeuchi K., Kitajima I.,
RA   Setou M., Ohtsuka T., Takai Y.;
RT   "SAD: a presynaptic kinase associated with synaptic vesicles and the
RT   active zone cytomatrix that regulates neurotransmitter release.";
RL   Neuron 50:261-275(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RA   Guo J.H., Yu L.;
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORS 5 AND 6).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 72-736 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B.,
RA   Cannata N., Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to
RT   yeast sequences.";
RL   Yeast 18:69-80(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 454-736 (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 463-736 (ISOFORM 3).
RX   PubMed=9929968; DOI=10.1007/s100380050096;
RA   Miura K., Miyoshi O., Yun K., Inazawa J., Miyamoto T., Hayashi H.,
RA   Masuzaki H., Yoshimura S., Niikawa N., Jinno Y., Ishimaru T.;
RT   "Repeat-directed isolation of a novel gene preferentially expressed
RT   from the maternal allele in human placenta.";
RL   J. Hum. Genet. 44:1-9(1999).
RN   [8]
RP   FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-174, AND
RP   MUTAGENESIS OF THR-174.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [9]
RP   PHOSPHORYLATION AT THR-260, AND MUTAGENESIS OF THR-260.
RX   PubMed=16870137; DOI=10.1016/j.bbrc.2006.06.178;
RA   Guo Z., Tang W., Yuan J., Chen X., Wan B., Gu X., Luo K., Wang Y.,
RA   Yu L.;
RT   "BRSK2 is activated by cyclic AMP-dependent protein kinase A through
RT   phosphorylation at Thr260.";
RL   Biochem. Biophys. Res. Commun. 347:867-871(2006).
RN   [10]
RP   PHOSPHORYLATION AT THR-174, AND MUTAGENESIS OF THR-174 AND GLY-310.
RX   PubMed=18339622; DOI=10.1074/jbc.M710381200;
RA   Bright N.J., Carling D., Thornton C.;
RT   "Investigating the regulation of brain-specific kinases 1 and 2 by
RT   phosphorylation.";
RL   J. Biol. Chem. 283:14946-14954(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-382 AND
RP   SER-393, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416 (ISOFORM
RP   4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393; SER-412
RP   AND THR-509, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION.
RX   PubMed=19958286; DOI=10.1042/BJ20091372;
RA   Fogarty S., Hawley S.A., Green K.A., Saner N., Mustard K.J.,
RA   Hardie D.G.;
RT   "Calmodulin-dependent protein kinase kinase-beta activates AMPK
RT   without forming a stable complex: synergistic effects of Ca2+ and
RT   AMP.";
RL   Biochem. J. 426:109-118(2010).
RN   [15]
RP   FUNCTION.
RX   PubMed=20026642; DOI=10.1242/jcs.058230;
RA   Muller M., Lutter D., Puschel A.W.;
RT   "Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and
RT   SadB-deficient neurons disrupts neuronal polarity.";
RL   J. Cell Sci. 123:286-294(2010).
RN   [16]
RP   INTERACTION WITH COPS5, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=22609399; DOI=10.1016/j.bbrc.2012.05.045;
RA   Zhou J., Wan B., Li R., Gu X., Zhong Z., Wang Y., Yu L.;
RT   "Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its
RT   degradation in the ubiquitin-proteasome pathway.";
RL   Biochem. Biophys. Res. Commun. 422:647-652(2012).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22713462; DOI=10.1016/j.bbrc.2012.06.046;
RA   Wang Y., Wan B., Li D., Zhou J., Li R., Bai M., Chen F., Yu L.;
RT   "BRSK2 is regulated by ER stress in protein level and involved in ER
RT   stress-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 423:813-818(2012).
RN   [18]
RP   FUNCTION, INTERACTION WITH PAK1, AND MUTAGENESIS OF LYS-48; THR-260
RP   AND THR-443.
RX   PubMed=22669945; DOI=10.1074/jbc.M112.378372;
RA   Nie J., Sun C., Faruque O., Ye G., Li J., Liang Q., Chang Z., Yang W.,
RA   Han X., Shi Y.;
RT   "Synapses of amphids defective (SAD-A) kinase promotes glucose-
RT   stimulated insulin secretion through activation of p21-activated
RT   kinase (PAK1) in pancreatic beta-Cells.";
RL   J. Biol. Chem. 287:26435-26444(2012).
RN   [19]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   LYS-48 AND THR-174.
RX   PubMed=22798068; DOI=10.1074/jbc.M112.375618;
RA   Chen X.Y., Gu X.T., Saiyin H., Wan B., Zhang Y.J., Li J., Wang Y.L.,
RA   Gao R., Wang Y.F., Dong W.P., Najjar S.M., Zhang C.Y., Ding H.F.,
RA   Liu J.O., Yu L.;
RT   "Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1
RT   negatively regulates glucose-stimulated insulin secretion in
RT   pancreatic beta-cells.";
RL   J. Biol. Chem. 287:30368-30375(2012).
RN   [20]
RP   CATALYTIC ACTIVITY, AND FUNCTION IN MAPT PHOSPHORYLATION.
RX   PubMed=21985311; DOI=10.1111/j.1471-4159.2011.07523.x;
RA   Yoshida H., Goedert M.;
RT   "Phosphorylation of microtubule-associated protein tau by AMPK-related
RT   kinases.";
RL   J. Neurochem. 120:165-176(2012).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, INTERACTION WITH FZR1,
RP   AND DOMAIN KEN BOX MOTIF.
RX   PubMed=23029325; DOI=10.1371/journal.pone.0045932;
RA   Li R., Wan B., Zhou J., Wang Y., Luo T., Gu X., Chen F., Yu L.;
RT   "APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation
RT   via the ubiquitin-proteasome pathway.";
RL   PLoS ONE 7:E45932-E45932(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays a key role in
CC       polarization of neurons and axonogenesis, cell cycle progress and
CC       insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1
CC       and WEE1. Following phosphorylation and activation by STK11/LKB1,
CC       acts as a key regulator of polarization of cortical neurons,
CC       probably by mediating phosphorylation of microtubule-associated
CC       proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also
CC       regulates neuron polarization by mediating phosphorylation of WEE1
CC       at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1
CC       activity in polarized neurons. Plays a role in the regulation of
CC       the mitotic cell cycle progress and the onset of mitosis. Plays a
CC       role in the regulation of insulin secretion in response to
CC       elevated glucose levels, probably via phosphorylation of CDK16 and
CC       PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin
CC       secretion (PubMed:22798068), BRSK2 phosphorylated at Thr-260 can
CC       promote insulin secretion (PubMed:22669945). Regulates
CC       reorganization of the actin cytoskeleton. May play a role in the
CC       apoptotic response triggered by endoplasmatic reticulum (ER)
CC       stress. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:20026642,
CC       ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:22669945,
CC       ECO:0000269|PubMed:22798068, ECO:0000269|PubMed:23029325}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- CATALYTIC ACTIVITY: ATP + [tau protein] = ADP + [tau protein]
CC       phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-174 by
CC       STK11/LKB1. {ECO:0000269|PubMed:14976552}.
CC   -!- SUBUNIT: Interacts with FZR1, a regulatory subunit of the APC
CC       ubiquitin ligase complex. Interacts with COPS5. Interacts with
CC       PAK1. {ECO:0000269|PubMed:22609399, ECO:0000269|PubMed:22669945,
CC       ECO:0000269|PubMed:23029325}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome. Cytoplasm, perinuclear region.
CC       Endoplasmic reticulum. Note=Detected at centrosomes during
CC       mitosis. Localizes to the endoplasmic reticulum in response to
CC       stress caused by tunicamycin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q8IWQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWQ3-2; Sequence=VSP_008154, VSP_008155;
CC       Name=3;
CC         IsoId=Q8IWQ3-3; Sequence=VSP_008156, VSP_008157;
CC       Name=4;
CC         IsoId=Q8IWQ3-4; Sequence=VSP_013945, VSP_008154, VSP_008155;
CC         Note=Contains a phosphoserine at position 416.
CC         {ECO:0000244|PubMed:19369195};
CC       Name=5;
CC         IsoId=Q8IWQ3-5; Sequence=VSP_022603, VSP_022604;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=Q8IWQ3-6; Sequence=VSP_055679, VSP_008154, VSP_008155;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in pancreas islets (at protein
CC       level). {ECO:0000269|PubMed:22798068}.
CC   -!- DOMAIN: The KEN box motif is required for interaction with
CC       FZR1/CDH1 and essential for APC(CDH1)-mediated ubiquitination.
CC       {ECO:0000269|PubMed:23029325}.
CC   -!- PTM: Phosphorylated at Thr-174 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Not
CC       phosphorylated at Thr-174 by CaMKK2. In contrast, it is
CC       phosphorylated and activated by CaMKK1. May be inactivated via
CC       dephosphorylation of Thr-174 by PP2C. Phosphorylated at Thr-260 by
CC       PKA. Phosphorylation at Thr-260 by PKA was not observed in another
CC       study (PubMed:18339622), but this may reflect differences in the
CC       experimental approach. Phosphorylation at Thr-260 seems to play a
CC       role in the regulation of insulin secretion (PubMed:22669945).
CC       {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:16870137,
CC       ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:19958286,
CC       ECO:0000269|PubMed:22669945}.
CC   -!- PTM: Polyubiquitinated by the APC complex in conjunction with
CC       FZR1, leading to its proteasomal degradation. Targeted for
CC       proteasomal degradation by interaction with COPS5. BRSK2 levels
CC       change during the cell cycle. BRSK2 levels are low at the G1/S
CC       boundary and gradually increase as cells progress into G2 phase.
CC       BRSK2 levels decrease rapidly at the end of mitosis.
CC       {ECO:0000269|PubMed:22609399, ECO:0000269|PubMed:23029325}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD09654.1; Type=Erroneous termination; Positions=663; Note=Translated as Gly.; Evidence={ECO:0000305};
CC       Sequence=AAD09654.1; Type=Frameshift; Positions=640; Evidence={ECO:0000305};
CC       Sequence=AAH24291.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY505125; AAS86443.1; -; mRNA.
DR   EMBL; AF533876; AAP97723.1; -; mRNA.
DR   EMBL; AF533877; AAP97724.1; -; mRNA.
DR   EMBL; AF533878; AAP97725.1; -; mRNA.
DR   EMBL; AF533879; AAP97726.1; -; mRNA.
DR   EMBL; AF533880; AAP97727.1; -; mRNA.
DR   EMBL; AY166857; AAN87839.1; -; mRNA.
DR   EMBL; AK122851; BAG53761.1; -; mRNA.
DR   EMBL; AK131534; BAD18671.1; -; mRNA.
DR   EMBL; AC091196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ006701; CAA07196.1; -; mRNA.
DR   EMBL; BC024291; AAH24291.1; ALT_INIT; mRNA.
DR   EMBL; AF020089; AAD09654.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS41590.1; -. [Q8IWQ3-3]
DR   CCDS; CCDS58106.1; -. [Q8IWQ3-2]
DR   CCDS; CCDS58107.1; -. [Q8IWQ3-1]
DR   CCDS; CCDS58108.1; -. [Q8IWQ3-5]
DR   CCDS; CCDS60696.1; -. [Q8IWQ3-6]
DR   RefSeq; NP_001243556.1; NM_001256627.1. [Q8IWQ3-1]
DR   RefSeq; NP_001243558.1; NM_001256629.1. [Q8IWQ3-2]
DR   RefSeq; NP_001243559.1; NM_001256630.1. [Q8IWQ3-5]
DR   RefSeq; NP_001269147.1; NM_001282218.1. [Q8IWQ3-6]
DR   RefSeq; NP_003948.2; NM_003957.3. [Q8IWQ3-3]
DR   UniGene; Hs.170819; -.
DR   ProteinModelPortal; Q8IWQ3; -.
DR   SMR; Q8IWQ3; -.
DR   BioGrid; 114491; 9.
DR   IntAct; Q8IWQ3; 3.
DR   STRING; 9606.ENSP00000310697; -.
DR   BindingDB; Q8IWQ3; -.
DR   ChEMBL; CHEMBL4574; -.
DR   GuidetoPHARMACOLOGY; 1947; -.
DR   iPTMnet; Q8IWQ3; -.
DR   PhosphoSitePlus; Q8IWQ3; -.
DR   BioMuta; BRSK2; -.
DR   DMDM; 116241272; -.
DR   EPD; Q8IWQ3; -.
DR   MaxQB; Q8IWQ3; -.
DR   PaxDb; Q8IWQ3; -.
DR   PeptideAtlas; Q8IWQ3; -.
DR   PRIDE; Q8IWQ3; -.
DR   DNASU; 9024; -.
DR   Ensembl; ENST00000308219; ENSP00000310697; ENSG00000174672. [Q8IWQ3-3]
DR   Ensembl; ENST00000382179; ENSP00000371614; ENSG00000174672. [Q8IWQ3-5]
DR   Ensembl; ENST00000526678; ENSP00000433370; ENSG00000174672. [Q8IWQ3-4]
DR   Ensembl; ENST00000528710; ENSP00000433235; ENSG00000174672. [Q8IWQ3-6]
DR   Ensembl; ENST00000528841; ENSP00000432000; ENSG00000174672. [Q8IWQ3-1]
DR   Ensembl; ENST00000529433; ENSP00000433684; ENSG00000174672. [Q8IWQ3-2]
DR   Ensembl; ENST00000531197; ENSP00000431152; ENSG00000174672. [Q8IWQ3-2]
DR   GeneID; 9024; -.
DR   KEGG; hsa:9024; -.
DR   UCSC; uc001lti.5; human. [Q8IWQ3-1]
DR   CTD; 9024; -.
DR   DisGeNET; 9024; -.
DR   GeneCards; BRSK2; -.
DR   H-InvDB; HIX0009361; -.
DR   HGNC; HGNC:11405; BRSK2.
DR   HPA; HPA073690; -.
DR   MIM; 609236; gene.
DR   neXtProt; NX_Q8IWQ3; -.
DR   OpenTargets; ENSG00000174672; -.
DR   PharmGKB; PA36212; -.
DR   eggNOG; KOG0588; Eukaryota.
DR   eggNOG; ENOG410XNQ0; LUCA.
DR   GeneTree; ENSGT00870000136462; -.
DR   HOGENOM; HOG000246447; -.
DR   HOVERGEN; HBG007240; -.
DR   InParanoid; Q8IWQ3; -.
DR   KO; K08796; -.
DR   OMA; NCMELMT; -.
DR   OrthoDB; EOG091G02CG; -.
DR   PhylomeDB; Q8IWQ3; -.
DR   TreeFam; TF313967; -.
DR   SignaLink; Q8IWQ3; -.
DR   SIGNOR; Q8IWQ3; -.
DR   GeneWiki; BRSK2; -.
DR   GenomeRNAi; 9024; -.
DR   PRO; PR:Q8IWQ3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000174672; -.
DR   CleanEx; HS_BRSK2; -.
DR   ExpressionAtlas; Q8IWQ3; baseline and differential.
DR   Genevisible; Q8IWQ3; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0060590; F:ATPase regulator activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0036503; P:ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043462; P:regulation of ATPase activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:1904152; P:regulation of retrograde protein transport, ER to cytosol; NAS:ParkinsonsUK-UCL.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Cell cycle;
KW   Cell division; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Endoplasmic reticulum; Exocytosis; Kinase; Magnesium; Metal-binding;
KW   Mitosis; Neurogenesis; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    736       Serine/threonine-protein kinase BRSK2.
FT                                /FTId=PRO_0000085670.
FT   DOMAIN       19    270       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      297    339       UBA.
FT   NP_BIND      25     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       603    605       KEN box.
FT   COMPBIAS    424    468       Pro-rich.
FT   ACT_SITE    141    141       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      48     48       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     174    174       Phosphothreonine; by LKB1.
FT                                {ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:18339622}.
FT   MOD_RES     260    260       Phosphothreonine; by PKA.
FT                                {ECO:0000269|PubMed:16870137}.
FT   MOD_RES     294    294       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:D3ZML2}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     412    412       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     422    422       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19958286}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     455    455       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     459    459       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     463    463       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     509    509       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     512    512       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     513    513       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   MOD_RES     520    520       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q69Z98}.
FT   VAR_SEQ       1     60       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_055679.
FT   VAR_SEQ       1     30       MTSTGKDGGAQHAQYVGPYRLEKTLGKGQT -> MSPEGHP
FT                                SRWARPRRPCICPSSLCSPREPRSGPAVGRGGAAHHRVPAG
FT                                HTPGPQLLQPHLHLPQGQTWLCLQPSPA (in isoform
FT                                5). {ECO:0000305}.
FT                                /FTId=VSP_022603.
FT   VAR_SEQ     408    408       Q -> QSKAMFSKSLDIAEAHPQFSKED (in isoform
FT                                4). {ECO:0000303|PubMed:16630837}.
FT                                /FTId=VSP_013945.
FT   VAR_SEQ     647    674       DTTNCMEMMTGRLSKCGSPLSNFFDVIK -> EPPPPAPGL
FT                                SWGAGLKGQKVATSYESSL (in isoform 2,
FT                                isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:11124703,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16630837,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008154.
FT   VAR_SEQ     663    678       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_022604.
FT   VAR_SEQ     664    668       SPLSN -> IIPKS (in isoform 3).
FT                                {ECO:0000303|PubMed:9929968,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008156.
FT   VAR_SEQ     669    736       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9929968,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008157.
FT   VAR_SEQ     675    736       Missing (in isoform 2, isoform 4 and
FT                                isoform 6). {ECO:0000303|PubMed:11124703,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:16630837,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008155.
FT   MUTAGEN      48     48       K->M: Loss of catalytic activity. Causes
FT                                disintegration of actin stress fibers.
FT                                {ECO:0000269|PubMed:22669945,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     174    174       T->A: Prevents phosphorylation and
FT                                activation by STK11/LKB1 complex.
FT                                {ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:18339622,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     174    174       T->E: Constitutively activated.
FT                                {ECO:0000269|PubMed:14976552,
FT                                ECO:0000269|PubMed:18339622,
FT                                ECO:0000269|PubMed:22798068}.
FT   MUTAGEN     260    260       T->A: Decreased phosphorylation. Nearly
FT                                abolishes stimulation of insulin
FT                                secretion. {ECO:0000269|PubMed:16870137,
FT                                ECO:0000269|PubMed:22669945}.
FT   MUTAGEN     310    310       G->A: Decreased activation of kinase
FT                                activity. {ECO:0000269|PubMed:18339622}.
FT   MUTAGEN     443    443       T->A: Constitutively activated. Promotes
FT                                formation of actin stress fibers.
FT                                {ECO:0000269|PubMed:22669945}.
FT   CONFLICT    251    251       I -> S (in Ref. 2; AAP97723/AAP97724/
FT                                AAP97725/AAP97726/AAP97727/AAN87839 and
FT                                5; CAA07196). {ECO:0000305}.
FT   CONFLICT    409    409       R -> G (in Ref. 3; BAG53761).
FT                                {ECO:0000305}.
SQ   SEQUENCE   736 AA;  81633 MW;  D9EBA511149449E6 CRC64;
     MTSTGKDGGA QHAQYVGPYR LEKTLGKGQT GLVKLGVHCV TCQKVAIKIV NREKLSESVL
     MKVEREIAIL KLIEHPHVLK LHDVYENKKY LYLVLEHVSG GELFDYLVKK GRLTPKEARK
     FFRQIISALD FCHSHSICHR DLKPENLLLD EKNNIRIADF GMASLQVGDS LLETSCGSPH
     YACPEVIRGE KYDGRKADVW SCGVILFALL VGALPFDDDN LRQLLEKVKR GVFHMPHFIP
     PDCQSLLRGM IEVDAARRLT LEHIQKHIWY IGGKNEPEPE QPIPRKVQIR SLPSLEDIDP
     DVLDSMHSLG CFRDRNKLLQ DLLSEEENQE KMIYFLLLDR KERYPSQEDE DLPPRNEIDP
     PRKRVDSPML NRHGKRRPER KSMEVLSVTD GGSPVPARRA IEMAQHGQRS RSISGASSGL
     STSPLSSPRV TPHPSPRGSP LPTPKGTPVH TPKESPAGTP NPTPPSSPSV GGVPWRARLN
     SIKNSFLGSP RFHRRKLQVP TPEEMSNLTP ESSPELAKKS WFGNFISLEK EEQIFVVIKD
     KPLSSIKADI VHAFLSIPSL SHSVISQTSF RAEYKATGGP AVFQKPVKFQ VDITYTEGGE
     AQKENGIYSV TFTLLSGPSR RFKRVVETIQ AQLLSTHDPP AAQHLSDTTN CMEMMTGRLS
     KCGSPLSNFF DVIKQLFSDE KNGQAAQAPS TPAKRSAHGP LGDSAAAGPG PGGDAEYPTG
     KDTAKMGPPT ARREQP
//
